Etomethazene
Identifiers
  • 2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-5-methyl-1H-benzimidazole-1-ethanamine
PubChem CID
Chemical and physical data
FormulaC23H31N3O
Molar mass365.521 g·mol−1
3D model (JSmol)
  • CCOc3ccc(Cc2nc1cc(C)ccc1n2CCN(CC)CC)cc3
  • InChI=1S/C23H31N3O/c1-5-25(6-2)14-15-26-22-13-8-18(4)16-21(22)24-23(26)17-19-9-11-20(12-10-19)27-7-3/h8-13,16H,5-7,14-15,17H2,1-4H3
  • Key:ZARKNPABJGEAOQ-UHFFFAOYSA-N

Etomethazene (5-methyldesnitroetonitazene) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since early 2022. It is an analogue of etonitazene where the nitro (NO2) group has been replaced by a methyl (CH3) group. While formal studies into its pharmacology have yet to be carried out, it showed far less potency than etonitazene itself. Etomethazene has a potency around 20 times than morphine with a relatively short duration about 120 min. [1][2]

See also

References

  1. ↑ "Early signal alert: Emergence of online mentions of etomethazene". National Drug Early Warning System. 1 July 2022.
  2. ↑ "5-methyl Etodesnitazene (citrate)". Caymanchem.com.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.